• 602-277-5551 x3045
  • Fax: 602-200-6051
  • 650 E Indian School Rd, RS151B, Phoenix, AZ 85012
Search
Close this search box.

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Arm, Placebo-Controlled Maintenance Study of Mirikizumab in Patients With Moderately to Severely Active Ulcerative Colitis (LUCENT 2)

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed prior 12-week induction study AMAN (NCT03518086).

Contributing Reseachers

Veterans’ Experiences

Participate in Research
“I joined a research trial because I want to help others. First, I served in the military. Now, I serve by participating in the Million Veterans Program.”
Joseph JamesSGT, USArmy (RET)

Our Research

Participate

Contribute

About

Contact

  • 650 E Indian School Rd, RS151B, Phoenix, AZ 85012